ClinicalTrials.Veeva

Menu
T

Tropical Clinical Trials | Palmetto Bay, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Duvakitug
SAR442970
MORF-057

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 6 total trials

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease (GARNET)

This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of 3 active dose regimens of M...

Enrolling
Crohn's Disease
Inflammatory Bowel Diseases
Drug: MORF-057
Drug: Placebo

This is a phase 2b, randomized, double-blind, 3-arm study for the treatment of Crohn's disease. The primary objective of this study is to assess the...

Enrolling
Crohn's Disease
Drug: SAR442970
Drug: Placebo

This is a phase 2b, randomized, double-blind, 3-arm study for the treatment of Ulcerative Colitis. The primary objective of this study is to assess t...

Enrolling
Ulcerative Colitis
Drug: SAR442970
Drug: Placebo

This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health problems, compared to a...

Active, not recruiting
COVID-19
SARS-COV-2 Infection
Biological: Placebo
Biological: BNT162b2 Vaccine
Locations recently updated

This is a multinational, multicenter, randomized, double-blind, placebo-controlled, Phase 3 induction study, comprised of 3 sub-studies, to evaluate...

Enrolling
Crohn's Disease
Drug: Duvakitug
Drug: Placebo

This is a multinational, multicenter, randomized, double-blind, placebo-controlled, Phase 3 induction study to evaluate the efficacy and safety of du...

Enrolling
Ulcerative Colitis
Drug: Placebo
Drug: Duvakitug

Trial sponsors

Sanofi logo
BioNTech logo
M

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems